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Stabilization of cytokine mRNAs in iNKT cells
requires the serine-threonine kinase IRE1alpha
Srinath Govindarajan1,2, Djoere Gaublomme1,2, Renée Van der Cruyssen1,2, Eveline Verheugen1,2,
Soﬁe Van Gassen3,4, Yvan Saeys3,4, Simon Tavernier5,6, Takao Iwawaki7, Yehudi Bloch8,9, Savvas.N. Savvides8,9,
Bart N. Lambrecht5,6,10, Sophie Janssens11,12, Dirk Elewaut1,2 & Michael B. Drennan 1,2
Activated invariant natural killer T (iNKT) cells rapidly produce large amounts of cytokines,
but how cytokine mRNAs are induced, stabilized and mobilized following iNKT activation is
still unclear. Here we show that an endoplasmic reticulum stress sensor, inositol-requiring
enzyme 1α (IRE1α), links key cellular processes required for iNKT cell effector functions in
speciﬁc iNKT subsets, in which TCR-dependent activation of IRE1α is associated with
downstream activation of p38 MAPK and the stabilization of preformed cytokine mRNAs.
Importantly, genetic deletion of IRE1α in iNKT cells reduces cytokine production and protects
mice from oxazolone colitis. We therefore propose that an IRE1α-dependent signaling cas-
cade couples constitutive cytokine mRNA expression to the rapid induction of cytokine
secretion and effector functions in activated iNKT cells.
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Invariant natural killer T (iNKT) cells are characterized as aninnate T-cell subset that recognizes glycolipid antigens pre-sented by CD1d, an MHC class I-related molecule1. A hall-
mark feature of iNKT cells is their ability to rapidly produce and
secrete immunomodulatory cytokines following T-cell receptor
(TCR) ligation, implicating them in a range of inﬂammatory,
allergic, and autoimmune diseases1. Although this functional
aspect of iNKT cell biology is not fully understood, it has been
suggested that the presence of preformed cytokine mRNAs as well
as histone acetylation of distinct cytokine loci facilitate rapid
iNKT cell cytokine production2,3. However, beyond such studies,
it has proved difﬁcult to investigate the potential regulatory
mechanisms involved in iNKT cell cytokine production as many
of these signaling pathways also control iNKT cell development,
maturation, and survival1,4. We therefore sought to investigate
whether iNKT cells utilize components of the unfolded protein
response (UPR) to accommodate the rapid increase in cytokine
production following activation as has been observed for the
production of antibodies during plasma cell differentiation5,6.
UPR is an intracellular signal transduction pathway conserved
from yeast to mammals that senses perturbations in protein
folding, protein synthesis and/or calcium homeostasis within the
endoplasmic reticulum (ER). In mammals, the UPR consists of
the three proximal ER stress sensors; inositol-requiring enzyme
1α (IRE1α), ER-resident protein kinase R-like endoplasmic reti-
culum kinase (PERK), and activating transcription factor 6
(ATF6) that collectively function to promote ER homeostasis by
increasing protein folding capacity and protein biosynthesis
within the ER during stress7. Prolonged or severe ER stress that
cannot be resolved by induction of the UPR is widely considered
to trigger apoptosis and inﬂammation and is involved in the
development of a number of human diseases characterized by a
metabolic or inﬂammatory pathology8.
IRE1α is a type I ER-resident transmembrane protein that
comprises an ER luminal and cytosolic domain with both serine-
threonine kinase and endoribonuclease activity9. During ER
stress, oligomerization of the luminal domain of IRE1α results in
autophosphorylation of the cytosolic domain and activation of a
sequence-speciﬁc endoribonuclease (RNase) which recognizes
and cleaves an intron from pre-mRNA encoding the bZIP tran-
scription factor XBP110. Translocation of cleaved or spliced XBP1
(XBP1s) to the nucleus is associated with the upregulation of ER
chaperone proteins and enzymes which function to increase
protein folding capacity and quality control within the ER11,12.
The RNase domain of IRE1α also targets and degrades distinct
mRNAs containing a consensus sequence in a process termed
regulated IRE1α-dependent decay (RIDD)13, further reducing
protein translocational load during ER stress. In addition to these
functions, autophosphorylation of IRE1α during UPR is also
associated with downstream c-Jun kinase (JNK) phosphoryla-
tion14, which is proposed to promote apoptosis in cells unable to
resolve ER stress15. ER stress however also activates additional ER
stress sensors including the protein kinase PERK and the tran-
scription factor ATF616,17. Here, the substrates for the protein
kinase activity of PERK have been identiﬁed, namely the eukar-
yotic translation initiation factor 2α (eIF2α). EIF2α has been
shown to counteract the formation of reactive oxygen species and
to inhibit cap-dependent mRNA translation18. ER stress-
mediated proteolysis of the ER luminal domain of ATF6 results
in the liberation of a bZIP transcription factor that induces genes
involved in ER chaperone function and ER-associated protein
degradation (ERAD)17,19. Collectively, UPR therefore promotes
ER homeostasis and cell survival by regulating an adaptive
response at both the transcriptional as well as translational level.
Irremediable ER stress is however associated with inﬂammatory
signaling and the initiation of apoptosis15.
Although it is widely acknowledged that UPR regulates cellular
survival during ER stress, several studies have shown that UPR is
also required by B lymphocytes during plasma cell
differentiation5,20. Here, XBP1s is required for the increased
synthesis and secretion of Ig chains by plasma cells5,6, suggesting
that IRE1α is directly activated during B-cell differentiation.
Similarly, T-cell differentiation following TCR ligation is asso-
ciated with the activation of IRE1α21, whereas PERK has been
shown to control T-cell effector functions by regulating the
translation of distinct cytokine mRNAs22.
In this study, we demonstrate that deﬁned iNKT sublineages
constitutively express components of the UPR, and require IRE1α
to stabilize cytokine mRNAs following activation both in vitro
and in vivo. We propose that these ﬁndings represent a novel
mechanism whereby IRE1α functions as a central regulator of
cytokine production for speciﬁc iNKT subsets in vivo.
Results
IRE1α RNase domain is active within NKT1 and 17 sub-
lineages. To assess steady-state UPR activity in T cells by ﬂow
cytometry, we analyzed expression of a variant of green ﬂuor-
escent protein (FP) in T cells isolated from the thymus, spleen
and liver of naïve ERAI-transgenic (ERAIFP/WT) mice23. We
utilized ERAIFP/WT mice as a UPR-speciﬁc reporter as they
express a partial sequence of human XBP-1 that includes the sites
at which IRE-1α splices XBP-1, fused to Venus ﬂuorescent protein
(VenusFP), which allows reporting of the IRE-1α arm of the
UPR23. Subsequent ﬂow cytometric analysis of the T-cell com-
partment using a Self-Organizing Map (FlowSOM)24 visually
deﬁned speciﬁc T-cell lineages as a minimal spanning (MS) tree
in which clusters of similar cells were represented as nodes within
each T-cell subset (Fig. 1a, c, e). In this manner, the MS trees
clearly identiﬁed distinct T-cell subsets within each organ as
either double-negative (DN, green) or double-positive (DP,
orange) thymocytes, CD4+ T cells (yellow), CD8+ T cells (red),
CD1d tetramer-negative NKT-like cells25 (light blue), iNKT cells
(dark blue) and γδ T cells (purple), respectively (Fig. 1a, c, e).
VenusFP expression within each node was subsequently deter-
mined by computing the difference between VenusFP expression
within T cells isolated from ERAIFP/WT mice and background
auto-ﬂuorescence in T cells isolated from littermate control
(ERAIWT/WT) mice. As is shown in Fig. 1b, d, f, the majority of
VenusFP expression was found to be restricted to iNKT cells
present in the spleen and liver; however, reporter expression was
also detected within peripheral iNKT and γδ T-cell lineages
(Fig. 1c, e). Data visualization of VenusFP expression using the
FlowSOM MS tree was therefore independently examined by
analyzing the expression of spliced and unspliced XBP1 mRNA
within FACS-sorted T-cell subsets isolated from thymus, spleen,
and liver of wild-type mice. Here, qPCR analysis veriﬁed that
splenic and hepatic iNKT cells expressed the highest level of
IRE1α RNase activity when compared to γδ and T-cell lineages
(Fig. 1g). A subsequent analysis of VenusFP expression within the
NKT1, 2 and 17 sublineages as deﬁned by the cell-surface mar-
kers CD27 and CD12226,27 revealed selective expression of
VenusFP within the NKT1 and NKT17 sublineages, respectively
(Fig. 1h). Notably, only NKT17 cells present in the spleen
expressed VenusFP whereas NKT2 cells isolated from the thymus,
spleen, liver, popliteal lymph node (PLN) and mediastinal lymph
node (MLN) did not (Fig. 1h). These results therefore show that a
constitutively active IRE1α RNase is present within the peripheral
iNKT cell compartment and that splenic and hepatic NKT1 and
NKT17 sublineages express the highest levels of XBP1s.
TCR ligation induces UPR in NKT1 and 17 sublineages.
iNKT cells have been shown to be activated by signals emanating
from their TCR1 as well as by cytokines such as IL-12 and type 1
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IFN28,29. We initially examined the role of TCR-dependent sig-
naling in regulating IRE1α RNase activity within iNKTs by sti-
mulating splenic iNKT sublineages in vitro using anti-CD3/
CD28. For these experiments, splenic NKT1a, NKT1b, NKT2, and
NKT17 sublineages were FACS sorted based on CD27 and
CD122 cell-surface expression and expanded in vitro as has been
previously reported26,27. Subsequent in vitro restimulation of
iNKT sublineages revealed that TCR-dependent stimulation
induced pronounced splicing of Xbp1 mRNA (Fig. 2a), as well as
several UPR-associated mRNAs (Fig. 2b) within the NKT17 and
NKT1, but not NKT2 sublineage cells. Importantly, we show that
TCR-induced splicing of Xbp1 mRNA within restimulated
iNKT cells (Fig. 2a) is associated with increased autopho-
sphorylation of IRE1α (Fig. 2c), suggesting that TCR-mediated
signaling within iNKT cells induces activation of the kinase
domain of IRE1α. A subsequent analysis of the ability of addi-
tional stimuli to induce Xbp1 mRNA splicing within in vitro
expanded iNKT cells revealed that neither cytokines such as IL-
12p70 and IFNβ, nor Toll-like receptor (TLR) agonists such as
lipopolysaccharide (LPS) or Poly (I:C) induced signiﬁcant IRE1α
RNase activity above that observed for medium controls (Fig. 2d).
These results were conﬁrmed in vivo using ERAIFP/WT mice
(Fig. 2e−h). Here, intraperitoneal (i.p.) administration of α-
galactosylceramide (α-GalCer), a TCR ligand, signiﬁcantly
increased VenusFP expression within splenic and hepatic
iNKT cells when compared to vehicle controls (Fig. 2e−h). In
contrast, induction of type 1 IFN following administration of Poly
(I:C) failed to modulate expression of VenusFP within iNKTs
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Fig. 1 Constitutive IRE1α RNase activity in iNKT cells of naïve ERA1- mice. a−f Minimal spanning tree visualization of T-cell subsets by FlowSOM analysis.
Manual gating results for a thymus, b spleen and c liver indicate which nodes correspond to the indicated T-cell subsets. Node size corresponds to the
percentage of cells represented by each node. b, d, f VenusFP expression within ERA1FP/WT and control ERA1WT/WT mice for thymus, spleen, and liver,
respectively (n= 3). Data represent three independent experiments. g Xbp-1s/u mRNA ratio expressed by T-cell subsets isolated from thymus, spleen, and
liver of C57Bl/6 mice (n= 5). Bar chart represents two independent experiments pooled. h VenusFP MFI within NKT1, 2 and 17 cells isolated from thymus,
spleen, PLN, MLN, and liver of ERA1FP/WT mice (n= 3). iNKTWT represents VenusFP MFI within control iNKT cells isolated from WT mice. Bar chart
represents one of three independent experiments. T lymphocyte subsets in (a−g) are deﬁned in Materials and Methods. Error bars show the mean ± s.e.m
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isolated from ERAIFP/WT mice (Fig. 2e−h). Thus, TCR-
dependent stimuli induce UPR and IRE1α RNase activity
within the NKT1 and NKT17 sublineages, both in vitro and
in vivo.
iNKT sublineage development is IRE1α-independent. IRE1α
has previously been shown to be required in pre-B cells during B-
cell receptor formation as well as for the secretion of immu-
noglobulins (Igs) during plasma cell differentiation5,30. In con-
trast, development and activation of the conventional T-cell
compartment is unaltered in the absence of IRE1α31, suggesting
that IRE1α regulates lymphocyte development and function in a
lineage-speciﬁc manner. We therefore sought to determine
whether iNKT cell development required IRE1α as iNKT cells
express a constitutively active IRE1α RNase (Fig. 1), and upre-
gulate spliced XBP1 mRNA following TCR stimulation (Fig. 2).
To examine the requirement for IRE1α during iNKT cell devel-
opment, we generated CD4 T-cell-speciﬁc IRE1α-deﬁcient mice
(CD4cre;IRE1αΔ/Δ) by intercrossing CD4-cre transgenic mice
with mice carrying a LoxP ﬂanked IRE1α allele. A subsequent
analysis of the frequency and absolute cell counts of iNKT cells
present in the thymus, spleen, and liver of CD4cre;IRE1αΔ/Δ mice
revealed no signiﬁcant differences when compared to littermate
IRE1αF/F controls (Supplementary Fig. 1A, B), and the develop-
ment and maturation of iNKT cell thymocytes from stage 1
(CD44loNK1.1−) to stage 3 (CD44hiNK1.1hi) iNKT cells occurred
normally in the absence of IRE1α (Supplementary Fig. 1C, D).
Similarly, analysis of iNKT sublineage development using the
transcription factors promyelocytic leukemia zinc ﬁnger (PLZF)
and RORγt revealed no signiﬁcant differences in the frequency or
absolute numbers of NKT1, NKT2 or NKT17 sublineages present
in thymus, spleen, and liver of CD4cre;IRE1αΔ/Δ mice relative to
controls (Supplementary Fig. 1E, F). To directly evaluate the
proliferative capacity of iNKT cells in the absence of IRE1α, DNA
labeling studies with BrdU were performed after administration
of mice intraperitoneally with α-GalCer. Analysis of iNKT cells
expansion after 5 days postinjection with α-GalCer revealed no
signiﬁcant differences between CD4cre;IRE1αΔ/Δ mice when
compared to littermate controls (Supplementary Fig. 1G). Thus,
IRE1α serves a limited role in the selection, maturation, and
lineage speciﬁcation of the iNKT cell compartment in steady-state
animals.
iNKT cell motility dynamics are IRE1α-independent. To fur-
ther analyze potential differences between wild-type and IRE1α-
deﬁcient iNKT cells, intravital motility dynamics of hepatic
iNKT cells were investigated using multiphoton microscopy. For
these experiments CD4cre;IRE1αΔ/Δ mice were backcrossed onto
a CXCR6gfp/− background as this mouse line has previously been
shown to be a reporter speciﬁc for hepatic iNKT cells1.
CXCR6gfp/−IRE1αF/F (IRE1αWT) and CXCR6gfp/−CD4cre;
IRE1αΔ/Δ (IRE1αKO) mice were subsequently imaged for 2 h at
steady-state until they received an i.v. injection with α-GalCer,
after which they were imaged for two more hours to capture the
TCR-mediated cell arrest that follows iNKT cell activation32. The
overall appearance and behavior of IRE1αWT and IRE1αKO mice
were very similar (Supplemental movies 1 and 2), apart from the
sporadic presence of clusters of GFP+ cells in the KO mice. We
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Fig. 2 TCR-dependent stimuli regulate activation of UPR in NKT sublineages. Expanded splenic NKT cell sublineages were restimulated with anti-CD3/
CD28 (3 μg.ml−1/5 μg.ml−1) for 3 h and fold induction of Xbp-1s/u (a) and ER chaperone mRNAs (b) in stimulated versus resting cells was assessed by
qPCR (n= 3). Bar chart represents two independent experiments pooled. c Analysis of phosphorylated IRE1α and total IRE1α in bulk expanded splenic
iNKT cells restimulated with α-CD3ε/CD28 for the indicated times via phos-tag immunoblot assay. β-Actin represents the loading control. Results
represent one of two independent experiments. d qPCR analysis of XBP1s in expanded splenic iNKT cells stimulated with α-GalCer (100 ng/ml), anti-CD3/
CD28 (3 μg.ml−1/5 μg.ml−1), PMA/Ionomycin (1 μΜ/200 ng.ml−1), LPS (20 ng/ml), Poly(I:C) (20 ng/ml), IFNβ (100 U/ml), IL-12p70 (20 ng/ml) or
medium (n= 3). Bar chart represents two independent experiments pooled. e−h Control and ERA1FP/WT mice were injected with either vehicle, α-GalCer
or Poly(I:C) and iNKT cells were analyzed in spleen and liver 2 h later. Histograms and bar graphs represent VenusFP expression within iNKT cells isolated
from the spleen and liver of WT (dashed line, n= 2), vehicle-injected ERA1FP/WT (gray, n= 3), α-GalCer-injected ERA1FP/WT (blue line, n= 3) or Poly(I:C)-
injected ERA1FP/WT mice (red line, n= 3) at 2 h postinjection. Histogram and bar chart represents one of three independent experiments. Error bars show
the mean ± s.e.m. *p < 0.05 determined by Mann–Whitney U test
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quantiﬁed the motility dynamics and showed that there was no
signiﬁcant difference in the average speed (Supplementary
Fig. 2A), speed distribution (Supplementary Fig. 2B), cell track
distribution (Supplementary Fig. 2C-F), displacement over time
(Supplementary Fig. 2G), and conﬁnement index (Supplementary
Fig. 2H) of GFP+ cells in IRE1αWT and IRE1αKO mice, respec-
tively. Plotting the squared displacement over time allows to
differentiate between different types of migration, with a linear
curve representing random movement, whereas for example an
upwards curve reveals directed movement. The conﬁnement
index is a measure of the straightness of the cell tracks, with a low
value indicating conﬁned movement, possibly caused by inter-
action with neighboring cells. As expected, iNKT cells show a
more conﬁned movement following injection with α-GalCer.
Overall, IRE1α does not appear to inﬂuence iNKT cell dynamics.
IRE1α speciﬁcally regulates NKT1 and 17 cytokine production.
To investigate whether UPR-mediated signaling regulates the
rapid secretion of effector cytokines by iNKT cells, we injected
control and CD4cre;IRE1αΔ/Δ mice intraperitoneally with α-
GalCer. Analysis of serum cytokines at 4 h postinjection revealed
signiﬁcantly reduced levels of IL-2, IL-4, IL-6, IFNγ, and TNFα in
CD4cre;IRE1αΔ/Δ mice compared to littermate controls (Fig. 3a,
upper panel). Similarly, signiﬁcantly fewer cytokine-positive
iNKT cells were detected in the spleens of CD4cre;IRE1αΔ/Δ
mice following injection of α-GalCer relative to controls (Fig. 3b),
and bulk splenic IRE1α-deﬁcient iNKT cells restimulated in vitro
secreted signiﬁcantly less cytokines than did control iNKT cells
(Fig. 3a, lower panel). Subsequent FACS sorting and expansion of
splenic iNKT sublineages from control and CD4cre;IRE1αΔ/Δ
mice revealed that NKT1 and NKT17 cells required IRE1α for the
production of cytokines following TCR restimulation (Fig. 3c), as
well as for the expression of cytokine mRNAs (Fig. 3d). In con-
trast, neither NKT2 cells nor polarized conventional CD4+ T cells
showed a requirement for IRE1α in the expression and translation
of cytokine mRNAs (Fig. 3c, d, and Supplementary Fig. 3A-C),
suggesting that IRE1α regulates cytokine mRNA expression
within the NKT1 and NKT17 sublineages.
Genetic deletion of IRE1α has previously been shown to result
in activation of the PERK signaling pathway33 which is
noteworthy as PERK promotes phosphorylation of eIF2α thereby
preventing cap-dependent translation of many cellular mRNAs.
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Fig. 3 Impaired cytokine production by IRE1α-deﬁcient iNKT cells. a Cytokines measured in serum from control (n= 11) and CD4cre;IRE1αΔ/Δ (n= 12) at 4 h
post-α-GalCer injection. Dot blots are representative of two independent experiments pooled. (Lower panel) Expanded iNKT splenocytes from control (n=
4) and CD4cre;IRE1αΔ/Δ (n= 4) mice were restimulated with anti-CD3/CD28 for 72 h and cytokines were measured in supernatant by ELISA. b FACS
histograms (upper panel) and absolute cell counts (lower panel) of cytokine-positive splenic iNKT cells isolated from control (black line, n= 4) and CD4cre;
IRE1αΔ/Δ (red line, n= 4) mice following injection of vehicle (isotype, gray) or α-GalCer at 60, 90, and 120min postinjection, respectively. Histograms and
bar charts are representative of two independent experiments. Supernatant cytokines (c) and cytokine mRNAs (d) from splenic NKT sublineages isolated
from control (n= 4) and CD4cre;IRE1αΔ/Δ (n= 4) mice following restimulation with anti-CD3/CD28 for 3 h. qPCR data are represented as fold mRNA
change in control versus knock-out (KO) cells. Dot blot and bar chart represents two independent experiments pooled. Phos-tag immunoblot analysis of
eIF2α and phosphorylated-eIF2α (e) in bulk expanded splenic iNKT cells isolated from control (n= 4) and CD4cre;IRE1αΔ/Δ (n= 4) mice following
restimulation with anti-CD3/CD28 at indicated time points. β-Actin represents the loading control. Results are representative of two independent
experiments. Error bars show the mean ± s.e.m. *p < 0.05, **p < 0.01 determined by Mann–Whitney U test and unpaired t test; n.d. not detected; n.s. not
signiﬁcant
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Reduced cytokine levels in IRE1α-deﬁcient iNKT cells may
therefore have been a consequence of enhanced PERK-eIF2α
activity. To control for this, we sorted and expanded bulk splenic
iNKT cells from control and CD4cre;IRE1αΔ/Δ mice and
restimulated them in vitro with anti-CD3/CD28 (Fig. 3e).
Importantly, both control and IRE1α-deﬁcient iNKT cells
expressed identical intracellular levels of eIF2α and phosphory-
lated eIF2α (Fig. 3e) following TCR-mediated restimulation,
conﬁrming that reduced cytokine levels in IRE1α-deﬁcient
iNKT cells is not a consequence of a general inhibition in mRNA
translation.
Cytokine mRNA stability within NKT1 and 17 requires IRE1α.
To examine whether IRE1α serves to regulate stabilization of
cytokine mRNAs within activated iNKT sublineages, we FACS
sorted NKT1, 2 and 17 sublineages from the spleens of control
and IRE1α-deﬁcient and expanded them in vitro as previously
described34. Following expansion, resting iNKT sublineages were
restimulated with anti-CD3/CD28 and then treated with actino-
mycin D to inhibit mRNA transcription. Here, the rate of mRNA
decay is expressed as the percentage mRNA remaining after the
zero timepoint of actinomycin D addition. As shown in Fig. 4a,
linear regression analysis of the percentage change in cytokine
mRNAs present in control and IRE1α-deﬁcient iNKT cells fol-
lowing addition of actinomycin D revealed a signiﬁcant difference
in the rate of cytokine mRNA decay within IRE1α-deﬁcient
NKT1 and NKT17, but not NKT2 sublineages. It is noteworthy
that an elevated mRNA decay rate was also observed for the
chemokine CCL3 within NKT1 cells, but not CCL5. Furthermore,
we found no signiﬁcant differences in the decay rates for several
mRNAs commonly associated with “housekeeping” functions
(e.g. Actb, Fig. 4a), suggesting that IRE1α regulates stability of
mRNAs associated with iNKT sublineage effector function. These
ﬁndings could be reproduced in expanded bulk splenic wild-type
iNKT cells treated pharmacologically with the IRE1α inhibitors
APY29 and B-109 (Fig. 4b, c). As observed for IRE1α-deﬁcient
iNKT cells, chemical inhibition of the kinase domain of IRE1α
with APY29 resulted in signiﬁcant mRNA decay rates for effector
cytokines and chemokines relative to vehicle controls (Fig. 4b).
Interestingly, chemical inhibition of the RNase domain of IRE1α
with B-I09 does not affect the mRNA decay rates for effector
cytokines and chemokines relative to vehicle controls (Fig. 4c).
Importantly, decreased cytokine mRNA stability was also
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Fig. 4 Reduced cytokine mRNA stability in IRE1α-deﬁcient iNKT cells. a Splenic NKT1, 2 and 17 cells were isolated from control (n= 4) and CD4cre;IRE1αΔ/Δ
(n= 4) mice, expanded and restimulated with anti-CD3/CD28 for 3 h prior to addition of actinomycin D. mRNA decay rates were determined by linear
regression analysis. Data represent three independent experiments pooled. b−d Bulk splenic wild-type iNKT cells were expanded in vitro, restimulated with
anti-CD3/CD28 for 3 h in the presence of APY29 and B-109, and then treated with actinomycin D. mRNA decay rates were determined as above. Data
represent two independent experiments pooled. e Puriﬁed bulk splenic iNKT cells from control (n= 6) and CD4cre;IRE1αΔ/Δ (n= 6) mice were
restimulated ex vivo with α-CD3/CD28 for 3 h, prior to addition of actinomycin D. Data represent two independent experiments pooled. Error bars show
the mean ± s.e.m. p < 0.05 determined by linear regression analysis and ANOVA, n.d. not detected
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observed in IRE1α-deﬁcient iNKT cells stimulated ex vivo relative
to controls (Fig. 4e). However, the effects of APY29 and B-I09 on
XBP1 splicing were maintained as described earlier35,36 (Fig. 4d).
Thus, effector mRNAs within activated NKT1 and 17 sublineages
are regulated by the kinase domain of IRE1α.
An IRE1α-p38 MAPK pathway regulates cytokine mRNA sta-
bility. During ER stress, oligomerization of the luminal domain of
IRE1α is associated with increased serine-threonine kinase
activity within the cytosolic domain of the protein9. The kinase
activity of IRE1α has been shown to be important in recruiting a
signaling complex consisting of TRAF2 14 or TRAF6 37 and
activation of the stress protein kinases c-Jun amino-terminal
kinase (JNK) and p38 mitogen-activated protein kinase (MAPK),
respectively14,38,39. Both JNK and p38 MAPK have been shown to
regulate gene expression within the T-cell compartment by reg-
ulating cytokine mRNA stability40,41, suggesting that IRE1α
might function within activated iNKT cells in a similar manner.
We next examined whether IRE1α regulates activation of the
JNK or p38 MAPK signaling pathways in TCR restimulated
iNKT cells. For these experiments, control and IRE1α-deﬁcient
iNKT cells were FACS sorted from the spleens of IRE1αF/F and
CD4cre;IRE1αΔ/Δ mice and expanded in vitro. Resting control and
IRE1α-deﬁcient iNKT cells were then restimulated with anti-
CD3/CD28 and analyzed for intracellular expression of JNK,
phosphorylated JNK (p-JNK), p38, and p-p38 by FACS. As
shown in Fig. 5a, b, JNK and p38 MAPK protein kinases become
phosphorylated in wild-type iNKT cells within the ﬁrst 10 min
following TCR restimulation. In contrast, IRE1α-deﬁcient
iNKT cells show a delayed phosphorylation kinetic for JNK
(Fig. 5a), whereas phosphorylation of p38 is almost completely
abolished when compared to control iNKT cells (Fig. 5b). To
examine the functional relevance of JNK or p38 phosphorylation
on cytokine mRNA stability in iNKT cells post TCR ligation, we
restimulated wild-type iNKT cells in the presence of the JNK
inhibitor BI-78D342, or the p38 MAPK inhibitor SB20358043,
prior to actinomycin D addition. Here, incubation of restimulated
iNKT cells with the JNK inhibitor BI-78D3 had a negligible effect
on cytokine mRNA stability when compared to vehicle controls
(Fig. 5c) whereas p38 MAPK activity was found to be essential for
maintaining stabilized mRNA transcripts in iNKT cells following
TCR ligation (Fig. 5d). We therefore conclude that both JNK and
p38 MAPK protein kinases are activated in iNKT cells post TCR-
ligation; however, the regulation of p38 MAPK activity by IRE1α
is needed to maintain cytokine mRNA stability following
activation.
IRE1α activity within iNKT cells regulates oxazolone colitis.
The above data show that IRE1α is an important regulator of
TCR-dependent cytokine production by iNKT cells. To evaluate
whether these ﬁndings were relevant to the development of
inﬂammation in a murine model of disease, we induced experi-
mental colitis in wild-type IRE1αF/F and CD4cre;IRE1αΔ/Δ mice
using oxazolone. Oxazolone is a haptenizing agent that induces
Th2-driven mucosal inﬂammation in a manner dependent on
CD1d and iNKT cells44,45. As shown in Fig. 6a, wild-type IRE1αF/
F mice that were rechallenged intrarectally with 1% oxazolone lost
signiﬁcantly more weight than did the oxazolone-treated CD4cre;
IRE1αΔ/Δ mice or ethanol-treated controls (Fig. 6a). Weight loss
within rechallenged wild-type IRE1αF/F mice was also associated
with signiﬁcantly reduced colon length (Fig. 6b), as well as
increased myeloperoxidase activity within distal colon samples
when compared to oxazolone-treated CD4cre;IRE1αΔ/Δ littermate
samples (Fig. 6c). In line with these ﬁndings, histopathology
scores were elevated in oxazolone-treated wild-type IRE1αF/F
mice compared with CD4cre;IRE1αΔ/Δ mice (Fig. 6l). Here, colons
of oxazolone-treated wild-type IRE1αF/F mice exhibited
inﬁltration of inﬂammatory cells into the mucosa and lamina
propria, as well as areas of mucosal erosion (Fig. 6h, i), that were
not observed in oxazolone-treated CD4cre;IRE1αΔ/Δ littermates or
ethanol-treated control mice (Fig. 6d−k). These results therefore
show that genetic deletion of IRE1α within iNKT cells protects
mice from mucosal inﬂammation in the oxazolone colitis mouse
model.
Discussion
We propose that IRE1α, a UPR sensor, links key cellular pro-
cesses involved in the regulation of cytokine production by acti-
vated iNKT cells. Results presented here show that TCR-mediated
stimulation of the NKT1 and NKT17 sublineages results in
autophosphorylation of IRE1α and subsequent splicing of XBP1,
a UPR-speciﬁc transcription factor, that is involved in remodeling
of the ER and preparing cells for enhanced cytokine secretion.
Activation of the kinase domain of IRE1α promotes downstream
activation of the p38 MAPK-signaling pathway which, in turn,
regulates cytokine mRNA stability within the NKT1 and
NKT17 sublineages. These ﬁndings provide a mechanistic link
between the induction of ER stress in iNKT cells and the reg-
ulation of organ-speciﬁc inﬂammation in mice, as shown here
using a murine model of intestinal inﬂammation.
Induction of ER chaperones and activation of the IRE1α-
dependent UPR signaling arm in iNKT cells after TCR ligation is
consistent with previous reports showing induction of UPR in
TCR-stimulated T cells31,46. These studies did however not dis-
criminate between CD4+ helper T cells and CD4+ iNKT cells
when analyzing UPR activity within bulk CD4+ T-cell lineages.
FlowSOM analysis of ERA1-transgenic mice performed in this
study clearly shows highest expression of constitutively active
IRE1α RNase within the iNKT cell lineage, particularly within
peripheral iNKT cells, with little to no IRE1α RNase activity
detected within the CD4+ or CD8+ T-cell compartments in
steady-state mice. Furthermore, an analysis of TCR-stimulated
TH-polarized CD4+ T cells in vitro showed no requirement for
IRE1α in regulating cytokine mRNA expression or stability,
arguing against a role for IRE1α-induced cytokine production in
conventional CD4+ T-cell lineages. Although induction of an ER
stress-response phenotype may be associated with priming of
CD4+ and CD8+ T-cell lineages21,22, constitutive IRE1α RNase
activity within peripheral NKT1 and NKT17 sublineages may be
comparable with a cellular phenotype observed within specialized
secretory cells. For example, terminal differentiation of mature B
cells into plasma cells requires both IRE1α and XBP1 5,30, and the
upregulation of genes encoding secretory pathway components in
plasma cells is coordinated by XBP1 12. Similarly, an IRE1-XBP1
signaling axis is needed for development and differentiation of
salivary gland acinar cells47, pancreatic beta cells48, and hepato-
cytes49. Although we found no requirement for IRE1α during
iNKT sublineage speciﬁcation and development, we propose that
IRE1α-dependent signaling promotes NKT1 and
NKT17 sublineage effector function in a manner analogous to the
role of IRE1-XBP1 signaling during immunoglobulin production
in plasma cells5,30. Similarly, TCR-dependent induction of ER-
associated protein chaperones in NKT1 and NKT17 cells would
facilitate increased cytokine protein folding and secretion both
in vitro and in vivo. The unexpected ﬁnding that IRE1α regulates
cytokine mRNA stability within restimulated NKT1 and
NKT17 sublineages is, to our knowledge, the ﬁrst dataset that
describes a mechanistic link between the maintenance of pre-
formed cytokine mRNAs within iNKT cells and their ability to
rapidly produce cytokines following activation3. Although tran-
scriptional regulation of Il4 mRNA within iNKTs has been pre-
viously associated with chromatin accessibility of the Il4 locus2,
our data show that IRE1α-mediated regulation of several cytokine
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mRNAs is an essential mechanism controlling iNKT cell effector
function. Importantly, incubation of iNKT cells with the kinase
inhibitor APY29 is associated with decreased cytokine mRNA
stability for in vitro expanded restimulated iNKT cells. However,
decreased cytokine mRNA stability within iNKT cells was not
affected in the presence of RNase domain inhibitor B-I09
(Fig. 4d). These ﬁndings are in agreement with a role for the
kinase domain of IRE1α in the downstream activation of protein
kinases such as JNK14. It remains to be determined how activa-
tion of IRE1α induces phosphorylation of p38 MAPK within
iNKT cells; however, we have been able to formally exclude a role
for either TRAF2 or TRAF6 in this signaling pathway (Supple-
mentary Fig. 4A).
Our ﬁndings are in line with a previous report describing a role
for MAPK kinase (MKK) 3, an upstream activator of the p38
MAPK pathway, in regulating cytokine production by
iNKT cells50. MKK3, p38, and the downstream kinase MAPK-
activated protein kinase (MAP-KAPK)-2 have been previously
associated with the stabilization of inﬂammatory mRNAs51. In
this context, a common characteristic of inﬂammatory mRNAs is
the presence of AU-rich sequences in their 3′ untranslated
regions. AU-rich elements (ARE) can act as potent mRNA
destabilizing sequences as they can target mRNA for rapid
deadenylation in vivo as well as promote 3′-5′ exonuclease
decay52. It has been proposed that p38-mediated stabilization of
inﬂammatory mRNAs is facilitated by a class of ARE-binding
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Fig. 5 p38 MAPK regulates cytokine mRNA stability in iNKT cells. a, b Bulk splenic iNKT cells from IRE1αF/F (n= 4) and CD4cre;IRE1αΔ/Δ (n= 4) mice
were expanded and restimulated with anti-CD3/CD28 from 0 to 90min. Histograms represent intracellular expression of JNK, phospho-JNK, p38 and
phospho-p38 in control and IRE1α-deﬁcient iNKT cells following TCR restimulation, respectively. Isotype controls (gray) are shown at the bottom of the
histogram overlays. Numbers in brackets represent MFI for JNK, p-JNK, p38 and p-p38 expression within FACS-gated iNKT cells. Histograms are
representative of three independent experiments. c, d Puriﬁed bulk splenic wild-type iNKT cells were restimulated ex vivo with anti-CD3/CD28 for 3 h in
the presence of the JNK inhibitor BI-78D3 (c) or the p38 inhibitor SB203580 (d), prior to addition of actinomycin D. Resting iNKT cells were then
restimulated with anti-CD3/CD28 for 3 h and then treated with actinomycin D. mRNA decay rates were determined by linear regression analysis. Data
represents three independent experiments pooled. Error bars show the mean ± s.e.m. p < 0.05 determined by linear regression analysis and ANOVA
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proteins (AREBP), such as TIA-1, which are functionally altered
following activation of the p38 MAPK signaling pathway53. It
remains to be determined whether IRE1α-p38-mediated stabili-
zation of cytokine mRNAs within iNKT cells requires down-
stream modulation of AREBP function; however, it is interesting
to note that TIA-1 has previously been shown to modulate IL-4
production within CD4+ T cells22.
Finally, the ﬁnding that CD4cre;IRE1αΔ/Δ mice are protected
from oxazolone colitis suggests that IRE1α-dependent signaling
contributes to iNKT cell effector function in vivo as well. These
results are signiﬁcant as it suggests that IRE1α-mediated stabili-
zation of cytokine mRNAs may be a general intracellular sig-
naling cascade required for modulating iNKT cell effector
function in vivo. Currently, a range of inﬂammatory, allergic and
autoimmune diseases are believed to be modulated by cytokines
secreted by iNKT cells in mouse and human. Although we were
able to show that inhibition of IRE1α kinase function using
APY29 inhibited cytokine mRNA stability in cultured iNKT cells,
in vivo administration of APY29 to target iNKT cell effector
function may have unwanted off-target side-effects such as
inhibition of exocrine gland and liver function47,49. We therefore
propose that a more detailed understanding of the mechanism by
which IRE1α regulates cytokine production in iNKT cells may
yield novel insights into signaling pathways that can be phar-
macologically targeted to either inhibit or augment iNKT cell-
driven disease.
Methods
Transgenic mice. Tg(CAG-XBP1*/Venus)#Miur (ERAI-transgenic) mice have been
previously described23. T-cell-speciﬁc IRE1α-deﬁcient mice (CD4cre;IRE1αΔ/Δ)
were generated by intercrossing mice carrying a LoxP ﬂanked IRE1α allele33 with
CD4-cre transgenic mice34. These transgenic mice were intercrossed with
CXCR6gfp mice for intravital imaging of iNKT cells as previously described32 All
mice were housed and bred according to the guidelines of the Ghent University
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Fig. 6 Deletion of IRE1α within iNKT cells protects mice from oxazolone colitis. IRE1αF/F control (n= 10) and CD4cre;IRE1αΔ/Δ (n= 10) mice were
presensitized with either ethanol (ETOH) or 3% oxazolone (OXA) and then challenged intrarectally with either ethanol or 1% oxazolone 7 days after
intrarectal challenge. Weight loss (a), colon length (b), MPO activity (c) and clinical score (l) were subsequently evaluated for each group after the
intrarectal challenge. Data represent mean values obtained from two independent experiments. d, f, h, j Photomicrographs (×10) of hematoxylin and eosin
(H&E)-stained sections of whole intestine removed from ethanol or oxazolone-treated control (d, h) and CD4cre;IRE1αΔ/Δ (f, j) mice 5 days after
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vivarium. All animal procedures were approved by the Institutional Animal Care
and Ethics Committee.
Flow cytometry and antibodies. Cells were analyzed on FACSCantoII (BD
Biosciences) and FlowJo software (Tristar), and sorted on FACS Aria III (BD
Biosciences). Antibodies used were CD122- PerCP-eFluor710 (TM-B1/46-1222-82/
1:200), CD19-eFluor 450 (eBio1D3/48-0193-82/1:300), CD24-FITC (M1-69/11-
0242-82/1:250), CD25-PE (PC61.5/12-0251-82/1:400), CD27-APC (LG.7F9/47-
0271-82/1:150), CD3ε-V500 (500A2/560771/1:100/BD Biosciences), CD4-FITC/
APC-eFluor780 (RM4-5/11-0042-82/17-00471-83/1:280), CD44-FITC/APC-
eFluor780 (IM7/11-0441-85/25-0441-U100/1:275), CD62L-PE-Cy7 (MEL-14/60-
0621-50U/1:600/TONBO), NK1.1-PE-Cy7 (PK136/25-5941-82/1:400), CD8α-
V500 (53-6.7/560776/1:300/ BD Biosciences), βTCR-APC-eFluor780 (H57-597/47-
5961-82/1:400), γδ ΤCR-PerCP-eFluor710 (eBioGL3/46-5711-82/1:250), IL2-PE-
Cy7 (JES6-5H4/25-7021-80/0.25 μg), IL4-APC (11B11/17-7041-82/0.25 μg), IL6-
FITC (MP5-20F3/561363/0.25 μg), IL13-PE-Cy7 (eBio13A//25-1733-80/0.25 μg),
IFNγ-FITC (XMG1.2/11-7311-81/0.25 μg), TNFα-APC (MP6-XT22/17-7321-81/
0.25 μg), T-bet-PE (eBio4B10/12-5825-82/0.25 μg), Gata-3-AlexaFluor488 (TWAJ/
14-9966-82/0.25 μg), RORγt-PE (B2D/12-6981-80/0.25 μg), PLZF-AlexaFluor488
(Mags.21F7/53-9320-82/0.25 μg) (all other antibodies are from Invitrogen/
eBioscience). p38α/β (A-12), JNK (D-2), β-Actin (from Santa Cruz Biotechnology,
p-p38 MAPK-AlexaFluor 488 (28B10), p-JNK-AlexaFluor 647 (G9), IRE-1α
(14C10/3294/1:1000), and EIF2α (9722/1ː1000) from Cell Signaling). α-GalCer-
loaded CD1d tetramers (1:400) and MR1-5-OP-RU-APC (NIH/1:800). iNKT cells
were stained at 4 °C using α-GalCer-loaded CD1d tetramers. MAIT cells were
stained at room temperature using MR1–5-OP-RU tetramer+ provided by NIH
tetramer core facility, USA. Stainings for intracellular proteins were performed
using the FoxP3/Transcription Factor staining buffer set (eBioscience) for iNKT
cell transcription factors or methanol for protein kinases according to the manu-
facturers’ recommendations. T lymphocyte subsets are deﬁned as DN (CD3ε−CD4
−CD8−); DP (CD3ε−CD4+CD8+); CD4+ T (CD4+CD8−CD1d-αGC−TCRβ+);
CD8+ T (CD4−CD8+CD1d-αGC−TCRβ+); iNKT (TCRβ+CD1d-αGC+); NKT-
Like (TCRβ+CD1d-αGC−NK1.1+), MAIT (MR1–5-OP-RU tetramer+ TCRβ+)
and γδ+ T (TCRγδ+TCRβ−). TCRβ+CD1d-αGC+ NKT sublineages are
deﬁned as NKT1 (CD27+/−IL-2Rβ+), NKT2 (CD27+IL-2Rβ−), and NKT17
(CD27−IL-2Rβ−).
FlowSOM analysis. FlowSOM analysis was performed as described previously24.
Brieﬂy, T-cell subsets were manually gated and the data for all the selected cells
were aggregated per tissue. FlowSOM analysis used intensity measurements for
NK1.1, CD4, α-GalCer-loaded CD1d tetramer, βTCR, γδ ΤCRand CD8α to group
the cells into 100 nodes where node size indicates the mean percentage of cells
assigned to the nodes. For analysis of VenusFP expression, the median VenusFP
expression was computed for each node per sample. The ﬁnal color value assigned
to the node corresponds to the difference between the mean of the values obtained
for ERAI-transgenic and wild-type mice, respectively.
Cell suspension preparations. Single cell suspensions from the thymus were
resuspended in phosphate-buffered saline (PBS) containing 1 mM ethylenediami-
netetraacetic acid (EDTA) and 0.5% bovine serum albumin (BSA) while spleen and
liver suspensions were layered over Ficoll or 33% Percoll gradients, respectively.
Peripheral blood mononuclear cells (MNCs) were isolated by cardiac puncture in
20 U/ml PBS/heparin. iNKT thymocytes were enriched for using mouse CD8-
Dynabeads (Invitrogen) and resuspended in 2 ml PBS containing 1 mM EDTA and
0.5% BSA.
iNKT cell isolation, expansion, and restimulation. iNKT cells were FACS sorted
from CD5-enriched MNCs isolated from the spleens or livers of pooled C57Bl/6,
IRE1αF/F or CD4cre;IRE1αΔ/Δ mice as described earlier54. Brieﬂy, α-GalCer/CD1d
tetramer+ TCRβ+ iNKT cells present within the lymphocyte were gated after
eliminating cell doublets, dead cells, CD19+ and γδT lymphocytes from the ana-
lysis by plotting FSC-H versus FCS-W, DAPI, CD19 (eFluor450), γδTCR (PerCp-
Cy5.5) versus FSC-A, respectively (Supplementary Fig. 5). For ex vivo stimulation
experiments, FACS-sorted iNKT cells were allowed to rest for 3 h after which 0.5 ×
106 iNKT cells were resuspended in complete RPMI 1640 medium (10% heat
inactivated FCS, 100 U/ml penicillin/streptomycin, 2 mM glutamine, 0.1 mM
nonessential amino acids, 5.5 × 102 µM µ-ME, all from GIBCO) and stimulated
with anti-CD3ε/CD28 (3 μg/ml, 5 μg/ml; eBioscience). For in vitro expansion
experiments, sorted splenic bulk iNKT or NKT sublineages were resuspended in
complete RPMI 1640 medium containing murine IL-2 (10 ng/ml), IL-12 (1 ng/ml),
and soluble anti-CD28 (1 µg/ml; all from eBioscience) and stimulated with plate-
bound anti-CD3ε (3 µg/ml) for 2 days. iNKT cells were then rested for 2 days and
resuspended in complete medium containing murine IL-7 (2 U/ml; eBioscience)
for 4 days. iNKT cells were then restimulated with plate-bound α-CD3ε (3 µg/ml)
for a further 3 days and subsequently expanded for an additional 10 days in the
presence of IL-7 and plate-bound anti-CD3ε, as described above. For restimulation
experiments, 1 × 106 iNKT cells were resuspended in complete RPMI 1640 medium
(10% heat inactivated fetal calf serum (FCS), 100 U/ml penicillin/streptomycin,
2 mM glutamine, 0.1 mM nonessential amino acids, 5.5 × 102 µM µ-ME, all from
GIBCO) and stimulated with either PMA/Ionomycin (1 μM/200 ng/ml, Sigma-
Aldrich), recombinant murine IL-12p70 (0.1 μg/ml, eBioscience), recombinant
murine IFNβ (0.1 mg/ml, eBioscience), LPS (20 ng/ml; Sigma-Aldrich), Poly I:C
(10 ng/ml; Sigma-Aldrich), 10 µg/ml murine CD1d (Sino Biological Inc.) loaded
with 100 ng/ml α-GalCer or anti-CD3ε/CD28 (3 μg/ml, 5 μg/ml). For cytokine
measurements, supernatants were collected after 72 h of stimulation and measured
by ELISA.
Immunoblot analysis and Phos-tag gels. Phosphorylation of IRE1α was mon-
itored by Phos-tag SDS gels according to the manufacturer’s instructions (NARD
Institute). Expanded bulk splenic iNKT cells (2 × 106 cells) were stimulated with
anti-CD3ε/CD28 (3 µg/ml, 5 µg/ml) for 0, 15, 30 and 60 min. Cells were spun for
10 min at 400 × g at 4 °C. After centrifugation, the medium was removed and
washed with cold PBS. Cells were lysed for 15 min on ice in E1A buffer (1% NP40,
20 mM HEPES, pH 7.9, 250 mM NaCl, 1 mM EDTA, and protease and phos-
phatase inhibitors). Insoluble material was discarded by cold centrifugation, and a
ﬁxed amount of lysate was mixed with sample buffer before separation by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). Samples were
separated using 6% SDS-PAGE containing 50 μM Phos-tag (NARD Institute) and
50 μM MnCl2. Gels were soaked in 1 mM EDTA before transfer for 10 min and
transferred onto 0.45 μM polyvinyldiﬂuoride membranes (Millipore). After transfer
to a membrane, proteins were visualized by enhanced chemiluminescence kit
(Thermo scientiﬁc).
Polarization and restimulation of naïve CD4+ T cells. Naïve CD4+ T cells
(CD4+TCRβ+CD1d-αGC−NK1.1−CD44−CD62Lhi) were FACS sorted from the
pooled spleens of IRE1αF/F (n= 5) and CD4cre;IRE1αΔ/Δ mice (n= 5), resuspended
in complete RPMI 1640 media containing polarizing cytokines and plated at 1 × 105
cells/well in 96-well plates coated with anti-CD3ε/α-CD28 (3 μg/ml, 5 μg/ml). Plated
CD4+ T cells were differentiated under TH1-polarizing conditions using recom-
binant murine IL-12 (10 ng/ml, eBioscience), recombinant murine IL-2 (10 ng/ml,
eBioscience), and anti-IL-4 (10 μg/ml, eBioscience); TH2-polarizing conditions
using recombinant murine IL-4 (10 ng/ml, eBioscience), recombinant murine IL-2
(10 ng/ml) and anti-IFNγ (10 μg/ml, eBioscience); and TH17-polarizing conditions
using recombinant murine IL-6 (20 ng/ml, eBioscience), recombinant murine IL-23
(10 ng/ml),55, recombinant murine IL-1β (10 ng/ml, PSF, VIB), recombinant
human TGFβ1 (2 ng/ml, eBioscience), anti-IL-4 (10 μg/ml), anti-IFNγ (10 μg/ml)
and anti-IL-2 (10 μg/ml, eBioscience), respectively. Cells were then removed from
TCR stimuli after 3 days, resuspended at 1 × 106/ml in fresh media and cultured in
a new 96-well plate without TCR stimuli for 2 days. 1 × 106 polarized T cells were
then resuspended in complete RPMI 1640 medium and restimulated using anti-
CD3ε/CD28 (3 μg/ml, 5 μg/ml; eBioscience).
In vivo stimulation of iNKT cells. For serum cytokine production, 5 μg of α-
GalCer in 200 ml PBS was injected intraperitoneally. Blood was subsequently
collected at by retro-orbital puncture at 4 h postinjection and assayed for cytokine
content by ELISA. For intracellular cytokine measurements, 2 μg of α-GalCer in
200 ml PBS was injected intraperitoneally and splenic iNKT cells were analyzed 2 h
later by ﬂow cytometry. For intravital imaging, 1 μg of α-GalCer in 20 μl PBS was
injected intravenously. For in vivo labeling with BrdU (Sigma-Aldrich), the mice
were injected i.p. with 1 mg BrdU (in PBS), followed by injection of 2 μg of α-
GalCer intraperitoneally. At the same time, BrdU (1 mg/ml) was placed in the
drinking water till the end of the experiment. Five days later, splenic iNKT cells
were analyzed for BrdU incorporation using a BrdU ﬂow kit (BD Biosciences)
according to the manufacturer’s instructions.
Intravital microscopy and image analysis. Multiphoton imaging of iNKT cells in
the liver was performed as described before56. Brieﬂy, to establish a baseline iNKT
cell speed, 2 h of steady-state images were recorded prior to injection with α-
GalCer. Imaging was continued for 2 h postinjection. Images were analyzed with
Imaris (Bitplane) using ImarisTrack to quantify iNKT cell speeds over time. Cell
velocities were plotted as a moving average of ten frames for each timepoint. Tracks
of individual iNKT cells, normalized to their starting coordinates, were plotted with
Matlab 9.1 (MathWorks). The square of the displacement distance over time was
shown at steady-state and 1 h postinjection. Finally, a conﬁnement index was
calculated by multiplying cell track straightness by the square root of the track
duration, both at steady-state and 1 h postinjection.
Quantitative real-time RT-PCR. Total RNA was extracted from T lymphocytes
analyzed in this study using the miRNeasy Mini kit (QIAGEN, Valencia, CA).
cDNA was produced and ampliﬁed using the QuantiTect Whole Transcriptome
Kit (QIAGEN, Valencia, CA). PCR products were ampliﬁed with the Fast Start
SYBR Green Master mix (Roche, Basel, Switzerland) and detected with a Light-
Cycler 480 System (Roche, Basel, Switzerland). Samples were normalized using
qBasePlus (Biogazelle NV, Belgium) against at least three of the following house-
keeping genes: Rpl13a, Atp5b, Eif4b, Cyc1, B2m, Ubc, Actb, Gapdh, Sdha or Tubb4a.
Primer sequences for housekeeping, cytokine, ER chaperone and UPR signature
genes are listed in Supplementary Table 1.
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RNA stability assays iNKT and differentiated CD4+ T-cell subsets were
stimulated with α-CD3ε/CD28 (3 µg/ml, 5 µg/ml) for 3 h after which 3 µg/ml of
actinomycin D (Sigma-Aldrich) was added. RNA was subsequently isolated from
actinomycin D-treated iNKT cells using the miRNeasy Mini kit (QIAGEN,
Valencia, CA). Cytokine mRNAs were then normalized against at least three
housekeeping genes expressed as the % mRNA remaining after the zero timepoint
of actinomycin D addition. The slope of the line for % mRNA remaining between 0
and 90 min post-actinomycin D addition was determined by linear regression for
each group or treatment condition. For inhibitor studies, anti-CD3ε/α-CD28-
stimulated iNKT cells were incubated in the presence of 20 µM APY29 (4865,
Tocris Bioscience), 20 µM B-109 (kindly provided by Andrew’s lab), 12.5 µM B1-
78D3 (Sigma-Aldrich), 2.5 µM SB-203580 (Sigma-Aldrich) or equivalent vehicle
controls prior to the addition of actinomycin D.
Induction of oxazolone colitis. Eight-week-old mice were presensitized with 200
µl of a 3% (w/v) solution of oxazolone (4-ethoxymethylene-2-phenyl-2-oxazoline-
5-one, Sigma-Aldrich) in 100% ethanol or 100% ethanol alone (vehicle) on the
abdominal skin. Five days later mice were anesthetized with a mixture of ketalar,
rompun and PBS and rechallenged intrarectally with 150 µl of either 1% (w/v)
oxazolone in 50% ethanol or 50% ethanol alone (vehicle).
Histology: Mice were euthanized 10 days after induction of oxazolone colitis.
The colons were subsequently removed and ﬁxed with 4% formalin (Sigma-
Aldrich). After parafﬁn embedding 7 µm sections were cut and stained with
hematoxylin–eosin.
Tissue myeloperoxidase activity. Samples of the mid-to-distal colon (adjacent to
the samples used for histology) were rinsed with cold PBS, blotted dry, and
immediately frozen in liquid nitrogen for storage at − 80 °C. Myeloperoxidase
(MPO) activity was determined using the O-dianisidine method.
Statistical analysis. Statistical testing was performed using the unpaired Student’s
t test unless otherwise indicated. The Mann–Whitney U test was applied when data
were demonstrated to not follow a Gaussian distribution, which is indicated in the
respective ﬁgures legends. Linear regression analysis and ANOVA were performed
for mRNA stability assays. Mixed model analysis was performed to assess differ-
ences in weight loss. All p values were two-tailed, and statistical signiﬁcance was
assumed at p < 0.05. For intravital imaging, linear mixed models for repeated
measures were used except for the speed distribution, for which binomial logistic
regression was performed.
Data availability
The data that support the ﬁndings in this study are available from the corre-
sponding author upon request.
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